SMEs from the biomanufacturing and medical technology sectors are eligible to apply for up to €60,000 under the BioMan4R2 Eurocluster funding scheme until July 2, 2023.
2 types of financial support are available:
Funding is available for collaborative projects between SMEs and partners from different sectors with common challenges related to resilience, sustainability or digital transformation, as well as evaluation and validation of existing products.
Funding will be provided for training in technology adoption, digitalization and sustainable supplier business models, as well as the development of training programs for SMEs in digitalization and digital skills. Also funded are resilience analyses, business continuity plans, market access strategies, advice on reimbursement or regulation.
For detailed information on the eligibility criteria and evaluation process, please refer to the BioMan4R2 Guidelines for Applicants
Use the BioMan4R2 matchmaking platform to find service providers or cooperation partners for the application as an applicant or to offer your services on the marketplace as a service provider.
If you would like to learn more about the application process and eligibility requirements, sign up for networking and attend our online info events:
1st date: May 4, 2023, 15:30 – 16:30 CEST Add 1st online event to your agenda.
2nd date: May 23, 2023, 10:00 – 11:00 CEST Add 2nd online event to your agenda.
For more information on the BioMan4R2 project, as well as application guidelines and application forms, please follow the Link.
Funded by the European Union. Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or EISMEA. Neither the European Union nor the granting authority can be held responsible for them
BioRegio STERN Management GmbH is the Financial Support Scheme Coordinator in the BioMan4R2 project as part of the European SMP COSME program, which provides financial support and networking for small and medium-sized enterprises in the fields of biological products and medical technology that want to increase their resilience, sustainability and competitiveness.